Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
Belgium- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to Sweden1 322 clinical trials in Helsingborg, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)
BelgiumEvaluation of FG001 imaging agent in patients with oropharyngeal and oral squamous cell carcinoma undergoing transoral robotic surgery or neck dissection
DenmarkAn observational study of carbidopa and levodopa use with a new dispensing device and app in patients with Parkinson's disease
SwedenTesting inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
SwedenA Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease
AustriaStudy of FG001 for Detecting Meningioma or Low-Grade Glioma in Patients Undergoing Neurosurgery
DenmarkStudy on the Safety and Effectiveness of Terbinafine Solution for Treating Mild to Moderate Nail Fungus in Children Aged 6-17 Years
DenmarkStudy of NTLA-2001 for Patients with Transthyretin Amyloidosis and Heart Disease
SwedenStudy on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer
SwedenStudy on Early Diffuse Cutaneous Systemic Sclerosis: Comparing Stem Cell Transplantation with Cyclophosphamide, Filgrastim, and Mycophenolate Mofetil
SwedenEfficacy and Safety of RO7568282 in Adults with Early Symptomatic Alzheimer’s Disease
BelgiumZenagamtide versus semaglutide: a study of blood sugar and weight reduction in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitor
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies exploring treatments for heart failure and cardiovascular conditions, including research on combination therapies to reduce cardiovascular mortality.
Groundbreaking trials evaluating novel drug combinations and therapeutic approaches for cardiac conditions.
Advanced research focusing on multiple myeloma treatment, particularly for patients with relapsed or refractory conditions.
Evaluating innovative therapeutic combinations and comparing effectiveness of different treatment regimens.
Clinical investigations into treatments for various infections, including bacterial infections and antibiotic resistance.
Studies focusing on alternative antibiotics and novel approaches to combat resistant infections.
Studies examining innovative treatments for psychiatric disorders, including treatment-resistant conditions.
Investigating immunomodulatory treatments and new compounds for mental health conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.